Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue 5
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical/translational cancer immunotherapy
Original research
Phase II trial of efficacy, safety and biomarker analysis of sintilimab plus anlotinib for patients with recurrent or advanced endometrial cancer
Online download statistics by month:
Online download statistics by month: May 2022 to October 2024
Abstract
Full
Pdf
May 2022
223
225
93
Jun 2022
449
452
206
Jul 2022
299
301
116
Aug 2022
282
288
106
Sep 2022
198
206
64
Oct 2022
212
212
83
Nov 2022
197
197
48
Dec 2022
121
121
43
Jan 2023
84
84
29
Feb 2023
101
103
51
Mar 2023
67
68
46
Apr 2023
68
69
35
May 2023
71
72
28
Jun 2023
67
67
35
Jul 2023
64
64
36
Aug 2023
57
57
31
Sep 2023
62
63
23
Oct 2023
47
47
31
Nov 2023
67
67
29
Dec 2023
50
51
34
Jan 2024
41
41
46
Feb 2024
62
62
33
Mar 2024
58
58
83
Apr 2024
47
47
37
May 2024
44
45
36
Jun 2024
63
62
40
Jul 2024
59
60
39
Aug 2024
52
49
24
Sep 2024
59
59
34
Oct 2024
58
58
30
Total
3329
3355
1569
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?